Puma concolor (puma): 112869500
Help
Entry
112869500 CDS
T08890
Symbol
PLCG1
Name
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
pcoo
Puma concolor (puma)
Pathway
pcoo00562
Inositol phosphate metabolism
pcoo01100
Metabolic pathways
pcoo01521
EGFR tyrosine kinase inhibitor resistance
pcoo04012
ErbB signaling pathway
pcoo04014
Ras signaling pathway
pcoo04015
Rap1 signaling pathway
pcoo04020
Calcium signaling pathway
pcoo04062
Chemokine signaling pathway
pcoo04064
NF-kappa B signaling pathway
pcoo04066
HIF-1 signaling pathway
pcoo04070
Phosphatidylinositol signaling system
pcoo04072
Phospholipase D signaling pathway
pcoo04360
Axon guidance
pcoo04370
VEGF signaling pathway
pcoo04517
IgSF CAM signaling
pcoo04613
Neutrophil extracellular trap formation
pcoo04650
Natural killer cell mediated cytotoxicity
pcoo04658
Th1 and Th2 cell differentiation
pcoo04659
Th17 cell differentiation
pcoo04660
T cell receptor signaling pathway
pcoo04664
Fc epsilon RI signaling pathway
pcoo04666
Fc gamma R-mediated phagosome formation
pcoo04670
Leukocyte transendothelial migration
pcoo04722
Neurotrophin signaling pathway
pcoo04750
Inflammatory mediator regulation of TRP channels
pcoo04919
Thyroid hormone signaling pathway
pcoo04933
AGE-RAGE signaling pathway in diabetic complications
pcoo04935
Growth hormone synthesis, secretion and action
pcoo05012
Parkinson disease
pcoo05022
Pathways of neurodegeneration - multiple diseases
pcoo05135
Yersinia infection
pcoo05167
Kaposi sarcoma-associated herpesvirus infection
pcoo05170
Human immunodeficiency virus 1 infection
pcoo05171
Coronavirus disease
pcoo05200
Pathways in cancer
pcoo05205
Proteoglycans in cancer
pcoo05206
MicroRNAs in cancer
pcoo05214
Glioma
pcoo05223
Non-small cell lung cancer
pcoo05225
Hepatocellular carcinoma
pcoo05231
Choline metabolism in cancer
pcoo05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
pcoo05417
Lipid and atherosclerosis
Module
pcoo_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
pcoo00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
112869500 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
112869500 (PLCG1)
04014 Ras signaling pathway
112869500 (PLCG1)
04015 Rap1 signaling pathway
112869500 (PLCG1)
04370 VEGF signaling pathway
112869500 (PLCG1)
04064 NF-kappa B signaling pathway
112869500 (PLCG1)
04066 HIF-1 signaling pathway
112869500 (PLCG1)
04020 Calcium signaling pathway
112869500 (PLCG1)
04070 Phosphatidylinositol signaling system
112869500 (PLCG1)
04072 Phospholipase D signaling pathway
112869500 (PLCG1)
09133 Signaling molecules and interaction
04517 IgSF CAM signaling
112869500 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
112869500 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
112869500 (PLCG1)
04660 T cell receptor signaling pathway
112869500 (PLCG1)
04658 Th1 and Th2 cell differentiation
112869500 (PLCG1)
04659 Th17 cell differentiation
112869500 (PLCG1)
04664 Fc epsilon RI signaling pathway
112869500 (PLCG1)
04666 Fc gamma R-mediated phagosome formation
112869500 (PLCG1)
04670 Leukocyte transendothelial migration
112869500 (PLCG1)
04062 Chemokine signaling pathway
112869500 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
112869500 (PLCG1)
04919 Thyroid hormone signaling pathway
112869500 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
112869500 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
112869500 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
112869500 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
112869500 (PLCG1)
05206 MicroRNAs in cancer
112869500 (PLCG1)
05205 Proteoglycans in cancer
112869500 (PLCG1)
05231 Choline metabolism in cancer
112869500 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
112869500 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
112869500 (PLCG1)
05214 Glioma
112869500 (PLCG1)
05223 Non-small cell lung cancer
112869500 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
112869500 (PLCG1)
05171 Coronavirus disease
112869500 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
112869500 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
112869500 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
112869500 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
112869500 (PLCG1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
112869500 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
112869500 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
112869500 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
pcoo04131
]
112869500 (PLCG1)
Enzymes [BR:
pcoo01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
112869500 (PLCG1)
Membrane trafficking [BR:
pcoo04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
112869500 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
112869500 (PLCG1)
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
PH
SH3_9
SH3_2
EF_HAND_2_PLCG
PH_12
GDPD
EF_HAND_1_PLCG
PH_9
Motif
Other DBs
NCBI-GeneID:
112869500
NCBI-ProteinID:
XP_025788426
UniProt:
A0A6P6IJN3
LinkDB
All DBs
Position
Unknown
AA seq
1059 aa
AA seq
DB search
MSLGVDIREIKEIRPGKTSRDFDRYQEDPAFRTDQSHCFVILYGMEFRLKTLSLQATSED
EVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRQNSSHVSEQLLENQRTQ
GGLPLAELGGRRVVLAQFVTFLFSKENSVWNSQLDAVCPETMNNPLSHYWISSSHNTYLT
GDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEH
AFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVDIAADGLPSPNQLKRKIL
IKHKKLAEGSAYEEVPTSVMYSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYS
EETSSDQGNEDEEEPKEASGSTELHSSEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPD
GSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGAPKFFLTDNLVFDSLYDLITHYQ
QVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPN
SYAISFRAEGKIKHCRVQQEGQTVVLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEA
LEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQN
VEKQEGGWWRGDYGGKKQLWFPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPA
CQIAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEG
KMMERRKKIALELSELVVYCRPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKF
LQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMAGGHC
GYVLQPSTMRDEAFDPFDKSSLRGLEPYAICIEIGRQLQVSTVGLGPEWRKPEAGYRAVP
LKNNYSEDLELASLLIKIEVFPAKENGDVSPFSSMSLRERGSDASGQLFHGRGREGSFEA
RYQQPFEDFRISQEHLADHFDSRERRAPRRTRVNGDNRL
NT seq
3180 nt
NT seq
+upstream
nt +downstream
nt
atgtctttaggtgttgacattcgagaaatcaaggagatccgcccagggaagacctcacgg
gattttgatcgctaccaagaggatcctgctttccgaacagaccagtcacactgctttgtc
atactgtatgggatggagttccgcctgaagaccctgagcctgcaagctacatctgaggat
gaagtgaacatgtggatcaaggggttaacttggctgatggaagatacattgcaggcggcc
acacctctgcagattgaaaggtggctgaggaagcagttctattcagtggatcggaatcgt
gaggatcgccagaacagtagccatgtctctgagcagctgctggagaaccagaggacccag
ggaggcctgcctttagcagagctggggggcaggcgagtggttctggcacaatttgtcacc
ttcctgttctccaaagagaacagtgtgtggaactcacagctggatgcagtgtgcccagaa
accatgaacaaccccctctcccactactggatctcctcctcccacaacacgtacctgacc
ggggaccagttctccagcgagtcctccctggaagcctacgctcgctgcctgcggatgggc
tgtcgctgcattgagttggactgctgggatggcccagatgggatgccagtcatttaccat
ggacacacccttaccaccaagatcaagttctcagacgtcctgcacactatcaaggagcac
gcctttgtggcctcagagtacccggtcatcctgtccattgaggaccattgcagcattgcc
cagcagaggaacatggcacagtacttcaagaaggtgcttggggacacactccttaccaag
cctgtggacatcgctgccgatggactcccctcacccaaccagctcaagaggaagatcctt
atcaagcacaagaagctggcagagggcagtgcctatgaagaggtgcctacatcagtgatg
tactccgagaacgatatcagcaactccatcaagaatggcatcctctacctggaggaccct
gtgaaccacgagtggtatccccactacttcgtcctgaccagcagcaaaatctactactct
gaggagacgagcagtgaccagggcaacgaggatgaggaggagcccaaggaggccagtggc
agcacagagctgcactccagtgagaaatggttccacgggaagctcggggcaggacgggat
gggcggcacatcgctgagcgcctgcttaccgagtactgcatcgagaccggggcccctgat
ggctccttcctcgtgcgagagagcgagaccttcgtgggcgactataccctctctttctgg
cggaatgggaaagtccagcactgccggatccactctcggcaggacgctggggcccccaag
ttcttcttgacagacaacctggtctttgactcgctctatgacctcatcacacactaccag
caggtgcccctacgctgcaacgaatttgagatgcgcctctcagagccagtcccgcagacc
aatgcccacgagagcaaagagtggtaccatgccagcctgaccagagctcaggccgagcac
atgctgatgcgcgtcccccgggatggggccttcctggtgaggaaacggaatgagcccaac
tcctacgccatctccttccgggctgagggcaagatcaagcattgccgcgtccagcaggag
ggccagacggtggtcctgggcaactcagagttcgacagcctcgtggacctcatcagctac
tatgagaagcacccactgtaccgcaagatgaagctgcgctatcccatcaacgaggaggcg
ctggagaagatcggcacagctgagccagactacggggccctgtatgagggccgcaaccca
ggcttctatgtggaggcgaatcctatgccgactttcaagtgtgcagtcaaagcactcttt
gactacaaggcccagagagaggatgagctgactttcactaagagcgccatcatccagaac
gtggagaagcaagaaggtggctggtggcggggggactatggtgggaagaagcagctgtgg
ttcccgtcaaactacgtggaagagatggtcagccccgcagccctggagcctgagagggag
cacttggacgagaacagccccttgggggatttgctccggggggtcttggatgtgccagct
tgtcagattgccatccgtcccgagggcaagaacaaccggctgttcgtcttctccatcagt
atggcttccgtggcgcactggtccctggatgtcgctgctgactcacaagaggagctgcag
gactgggtgaagaagatccgagaagtggcccagacggcagacgccaggctcacggagggc
aagatgatggagcggaggaagaagatcgccctggagctctccgagctggttgtctactgt
cggcctgttccctttgatgaagagaagattggcacagaacgtgcctgctaccgggacatg
tcgtccttcccggaaaccaaggctgagaaatacgtgaacaaggccaaaggcaagaagttt
ctccagtataaccggctgcagctctcccgcatctaccccaagggccagcggctggactcc
tccaattacgaccccttgcccatgtggatctgtggcagtcagctcgtggctctcaacttc
cagaccccagacaagcctatgcagatgaaccaggccctcttcatggccggtggccactgt
ggctacgtgctgcagccgagcaccatgcgggatgaggcctttgatccctttgacaagagc
agcctccgaggcctggagccatatgccatctgcatcgagataggaaggcagctgcaagtc
tccaccgtggggctgggcccagagtggcgaaagcccgaggcaggatacagagccgtgcct
ttgaagaacaactacagtgaggacctggagctggcctccctgctcatcaagatcgaggtt
ttccctgccaaggagaacggtgacgtcagtcccttcagtagtatgtctctgcgcgagcgg
ggctccgatgcctcgggtcagctgttccatggccggggccgggaaggttcctttgaagcc
cgctaccagcagccgtttgaggactttcgtatctcccaagagcatctggcagaccatttt
gacagtcgggaacggagggccccacgaaggactcgggtcaacggggacaaccgcctctag
DBGET
integrated database retrieval system